|
End-of-day quote
Taiwan S.E.
28/10/2026
|
5-day change | 1st Jan Change | ||
| 48.40 TWD | -0.82% |
|
-1.43% | -21.56% |
| 10-07 | EirGenix Submits European Marketing Application for Breast Cancer Biosimilar | MT |
| 09-10 | EirGenix Completes Capital Reduction Following RSA Write-Off | MT |
| Market Cap | 14.45B 445M 400M 369M 335M 625M 42.42B 633M 4.42B 1.76B 22.2B 1.67B 1.64B 70.48B | P/E 2026 * |
-31.8x | P/E 2027 * | 84.9x |
|---|---|---|---|---|---|
| Enterprise Value | 13.21B 407M 365M 338M 306M 571M 38.76B 578M 4.04B 1.61B 20.28B 1.53B 1.5B 64.4B | EV / Sales 2026 * |
8.96x | EV / Sales 2027 * | 5.81x |
| Free-Float |
59.34% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.82% | ||
| 1 week | -1.43% | ||
| Current month | -9.36% | ||
| 1 month | -5.84% | ||
| 3 months | +2.87% | ||
| 6 months | +4.99% | ||
| Current year | -21.56% |
| 1 week | 48.15 |  | 50.1 |
| 1 month | 48.15 | | 54 |
| Current year | 40.15 | | 67.6 |
| 1 year | 40.15 | | 84.3 |
| 3 years | 40.15 | | 111 |
| 5 years | 40.15 | | 163.5 |
| 10 years | 21.55 | | 195 |
| Manager | Title | Age | Since |
|---|---|---|---|
Li Cheng Liu
CEO | Chief Executive Officer | - | 01/04/2013 |
Hsiu Chuan Yang
DFI | Director of Finance/CFO | - | 03/05/2016 |
Yu Wen Liu
PRN | Corporate Officer/Principal | - | 20/05/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Cheng Yue Cheng
BRD | Director/Board Member | - | 14/06/2013 |
Ming Hsien Chen
BRD | Director/Board Member | - | 13/09/2016 |
Fu Hsiu Yin
BRD | Director/Board Member | - | 13/09/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.82% | -1.43% | -28.30% | -54.34% | 449M | |
| +0.54% | +1.38% | +57.08% | +127.72% | 1,143B | |
| +0.80% | +4.93% | +44.70% | +83.96% | 647B | |
| +0.38% | +0.90% | +26.29% | +102.52% | 506B | |
| -0.05% | +1.73% | +52.74% | +65.27% | 384B | |
| -0.86% | -6.09% | +61.73% | +37.08% | 350B | |
| +0.34% | +1.84% | +30.70% | +52.69% | 293B | |
| -0.45% | +1.19% | +2.89% | +24.92% | 265B | |
| +0.43% | +2.61% | +53.99% | +70.90% | 242B | |
| +0.27% | +3.79% | +35.21% | +104.94% | 197B | |
| Average | +0.07% | +0.62% | +33.70% | +61.56% | 402.8B | |
| Weighted average by Cap. | +0.29% | +0.71% | +44.46% | +86.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.47B 45.42M 40.75M 37.68M 34.12M 63.75M 4.33B 64.52M 451M 179M 2.26B 170M 167M 7.19B | 2.34B 72.2M 64.78M 59.89M 54.24M 101M 6.88B 103M 716M 285M 3.6B 271M 265M 11.42B |
| Net income | -458M -14.11M -12.66M -11.71M -10.6M -19.81M -1.34B -20.05M -140M -55.75M -703M -52.96M -51.85M -2.23B | 172M 5.3M 4.76M 4.4M 3.98M 7.44M 505M 7.53M 52.57M 20.94M 264M 19.89M 19.47M 839M |
| Net Debt | -1.25B -38.43M -34.48M -31.88M -28.87M -53.94M -3.66B -54.59M -381M -152M -1.92B -144M -141M -6.08B | -838M -25.82M -23.17M -21.42M -19.4M -36.25M -2.46B -36.68M -256M -102M -1.29B -96.91M -94.86M -4.09B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | NT$48.40 | -0.82% | 414,029 |
| 27/10/26 | NT$48.80 | -1.81% | 333,450 |
| 22/10/26 | NT$49.70 | +0.71% | 290,030 |
| 21/10/26 | NT$49.35 | +0.51% | 232,203 |
| 20/10/26 | NT$49.10 | +0.61% | 238,581 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6589 Stock
Select your edition
All financial news and data tailored to specific country editions
